Cargando…

Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer

PURPOSE: To determine the long-term efficacy of adjuvant immunotherapy with autologous cytokine-induced killer (CIK) cells for locally advanced gastric cancer patients. EXPERIMENTAL DESIGN: One hundred and fifty-one patients with stage III/IV gastric cancer who had undergone gastrectomy were enrolle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Liangrong, Zhou, Qi, Wu, Jun, Ji, Mei, Li, Guojun, Jiang, Jingting, Wu, Changping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506195/ https://www.ncbi.nlm.nih.gov/pubmed/22674056 http://dx.doi.org/10.1007/s00262-012-1289-2

Ejemplares similares

Cytokine-induced killer cells promote antitumor immunity
por: Jiang, Jingting, et al.
Publicado: (2013)

Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells
por: LI, ZHENGGUANG, et al.
Publicado: (2014)

Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection
por: Pan, Qiu-Zhong, et al.
Publicado: (2020)

The combination of systemic chemotherapy and local treatment may improve the survival of patients with unresectable metastatic colorectal cancer
por: Zhao, Jiemin, et al.
Publicado: (2017)

Computed tomography-guided permanent brachytherapy for locoregional recurrent gastric cancer
por: Shi, Liangrong, et al.
Publicado: (2012)

Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer
por: Chen, Yu, et al.
Publicado: (2015)

Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies
por: Yang, Yang, et al.
Publicado: (2021)

A rare case of eight multiple primary malignant neoplasms in a female patient: A case report and review of the literature
por: ZHAO, JIEMIN, et al.
Publicado: (2015)

Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer
por: Yang, Xinyi, et al.
Publicado: (2022)

A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma
por: Pan, Qiu-Zhong, et al.
Publicado: (2015)

Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
por: Lee, Jeong-Hoon, et al.
Publicado: (2018)

Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis
por: Yu, Ruili, et al.
Publicado: (2017)

Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients
por: Chen, Lujun, et al.
Publicado: (2016)

Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery
por: Li, Xiao, et al.
Publicado: (2022)

Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
por: Du, Hansong, et al.
Publicado: (2020)

MiR-629 promotes human pancreatic cancer progression by targeting FOXO3
por: Yan, Haijiao, et al.
Publicado: (2017)

Prognostic value of tumor infiltrating NK cells and macrophages in stage II+III esophageal cancer patients
por: Xu, Bin, et al.
Publicado: (2016)

Efficacy of Cytokine-Induced Killer Cell Immunotherapy for Patients With Pathologically Pure Glioblastoma
por: Han, Myung-Hoon, et al.
Publicado: (2022)

Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis
por: Tang, Peijun, et al.
Publicado: (2022)

Cytokine-induced killer cell/dendritic cell–cytokine-induced killer cell immunotherapy for the postoperative treatment of gastric cancer: A systematic review and meta-analysis
por: Wang, Xiang, et al.
Publicado: (2018)

The necessity of adjuvant radiotherapy for locally advanced gastric cancer in China
por: Yang, Yongqiang, et al.
Publicado: (2019)

Retrospective analysis of the efficacy of cytokine‐induced killer cell immunotherapy combined with first‐line chemotherapy in patients with metastatic colorectal cancer
por: Pan, Qiu‐Zhong, et al.
Publicado: (2020)

Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer
por: Shi, Hongbing, et al.
Publicado: (2014)

Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer Cells
por: Kim, Ji Sung, et al.
Publicado: (2016)

Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer
por: Liu, Guiyuan, et al.
Publicado: (2022)

Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials
por: Wang, Yan, et al.
Publicado: (2017)

Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
por: Yoon, Jun Sik, et al.
Publicado: (2019)

Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy: A propensity score analysis
por: Zhao, Jing-Jing, et al.
Publicado: (2018)

Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors
por: Sangiolo, Dario
Publicado: (2011)

Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy
por: Gao, Xingchun, et al.
Publicado: (2017)

Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer
por: Chen, Dan, et al.
Publicado: (2018)

Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer
por: Miura, Yuki, et al.
Publicado: (2021)

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer
por: Dehno, Mojgan Naghizadeh, et al.
Publicado: (2020)

Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients
por: Zhang, Yuhan, et al.
Publicado: (2019)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis
por: Yuan, Xin, et al.
Publicado: (2021)

Cytokine-induced killer cells: A novel immunotherapy strategy for leukemia
por: YANG, XIN-YU, et al.
Publicado: (2015)

Cytokine-induced memory-like natural killer cells for cancer immunotherapy
por: Tarannum, Mubin, et al.
Publicado: (2021)

The role of different adjuvant therapies in locally advanced gastric adenocarcinoma
por: Benevento, Ilaria, et al.
Publicado: (2018)

Higher Numbers of T-Bet(+) Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian Cancer
por: Xu, Yun, et al.
Publicado: (2017)

Cost-Effectiveness of Adjuvant Immunotherapy With Cytokine-Induced Killer Cell for Hepatocellular Carcinoma Based on a Randomized Controlled Trial and Real-World Data
por: Cho, Jeong-Yeon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3c7k12otichbdf2mfu47pepb20